Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice by Valérie Jooste, Leila Bengrine-Lefevre, Sylvain Manfredi, Valérie Quipourt, Pascale Grosclaude, Olivier Facy, Côme Lepage, François Ghiringhelli, Anne-Marie Bouvier

Subjects: Get full text

Response rates to a mailed survey of a representative sample of cancer patients randomly drawn from the Pennsylvania Cancer Registry: a randomized trial of incentive and length effects by Hornik Robert C, Fraze Taressa K, Kelly Bridget J

“…</p> <p>Methods</p> <p>In a pilot study, 1200 breast, prostate and colon patients, randomly selected from the Pennsylvania Cancer Registry, were sent surveys in the mail. Incentive amount ($3 vs. $5) and length of the survey (10 pages vs. 16 pages) were randomly assigned.…”
Get full text

The impact of early‐stage COVID‐19 pandemic on the diagnosis and treatment of gastric cancer: A cross‐sectional study using a large‐scale cancer registry in Hiroshima, Japan by Masanobu Kodama, Daisuke Miyamori, Keishi Kanno, Masanori Ito

Get full text

LONG-TERM RESULTS OF NASOPHARYNGEAL CARCINOMA TREATMENT (BASED ON THE ANALYSIS OF CASES FROM CANCER REGISTRY OF N.N. BLOKHIN RUSSIAN CANCER RESEARCH CENTER DURING 1980–2010) by T. D. Tabolinovskaya, A. M. Mudunov, R. I. Azizyan, I. N. Pustynskiy, T. A. Aketova

Get full text

Renal Cell Carcinoma Health Disparities in Stage and Mortality among American Indians/Alaska Natives and Hispanic Americans: Comparison of National Cancer Database and Arizona Cancer Registry Data by Celina I. Valencia, Samer Asmar, Chiu-Hsieh Hsu, Francine C. Gachupin, Ava C. Wong, Juan Chipollini, Benjamin R. Lee, Ken Batai

“…RCC patients’ data were obtained from the National Cancer Database (NCDB) and Arizona Cancer Registry (ACR). Logistic and Cox regression analyses were performed to ascertain the effect of race/ethnicity on stage and mortality, adjusting for neighborhood socioeconomic factors, rural/urban residence pattern, and other factors. …”
Get full text

BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010–2013: An observational study using state cancer registry and All‐Payer claims data by Lydia E. Pace, John Z. Ayanian, Robert E. Wolf, Richard Knowlton, Susan T. Gershman, Summer Sherburne Hawkins, Nancy L. Keating

“…Methods We identified breast cancer diagnoses in the Massachusetts Cancer Registry from 2010 to 2013 and linked registry data with Massachusetts All‐Payer Claims Data from 2010 to 2014 among women aged ≤45 years with private insurance or Medicaid. …”
Get full text

Comment on “Does Esophagectomy Provide a Survival Advantage to Patients Aged 80 Years or Older? Analyzing 5066 Patients in the National Database of Hospital-based Cancer Registries in Japan” by Nezih Akkapulu, MD, FACS

Get full text

Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO). by Mari Kajiwara Saito, Toshitaka Morishima, Chaochen Ma, Shihoko Koyama, Isao Miyashiro

“…<h4>Methods</h4>We conducted a multi-center cohort study, using hospital-based cancer registry (HBCR) data linked to administrative data from 66 designated cancer care hospitals in Osaka. …”
Get full text

Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000–2015 by Danielle Awounou, Brigitte Lacour, Emmanuel Desandes, Sandra Guissou, Nathalie Cassoux, François Doz, Christelle Dufour, Véronique Minard‐Colin, Gudrun Schleiermacher, Sophie Taque, Arnauld Verschuur, Jacqueline Clavel, Stéphanie Goujon

Subjects: Get full text

Second Primary Cancers in a Population-Based Mesothelioma Registry by Carolina Mensi, Simona Stella, Barbara Dallari, Sabrina Rugarli, Angela Cecilia Pesatori, Giovanni Luca Ceresoli, Dario Consonni

Subjects: Get full text

The incidence and trends of laryngeal malignancies in Sri Lanka from 2001 to 2019: a Joinpoint analysis of the national cancer database by Umesh Jayarajah, Ravindri Jayasinghe, Ashan Fernando, Sanjeewa Seneviratne

Subjects: Get full text

Projecting cancer prevalence by phase of care: a methodological approach for health service planning by Silvia Francisci, Francesco Tursini, Luigino Dal Maso, Anna Gigli, Stefano Guzzinati

Subjects: Get full text

Survival of Patients with Sinonasal Cancers in a Population-Based Registry, Lombardy, Italy, 2008–2023 by Dario Consonni, Simona Stella, Nerina Denaro, Alessandra Binazzi, Barbara Dallari, Sabrina Rugarli, Flavia Borello, Enzo Coviello, Carolina Mensi

Subjects: Get full text

Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany by Annika Waldmann, Pia Borchers, Alexander Katalinic

Subjects: Get full text

An Ontology to Model the International Rules for Multiple Primary Malignant Tumours in Cancer Registration by Nicholas Charles Nicholson, Francesco Giusti, Manola Bettio, Raquel Negrao Carvalho, Nadya Dimitrova, Tadeusz Dyba, Manuela Flego, Luciana Neamtiu, Giorgia Randi, Carmen Martos

Subjects: “…cancer registry…”
Get full text

Breast cancer and occupation: Non-parametric and parametric net survival analyses among Swiss women (1990–2014) by Irina Guseva Canu, Nicolas Bovio, Patrick Arveux, Jean-Luc Bulliard, Jean-Luc Bulliard, Evelyne Fournier, Simon Germann, Isabelle Konzelmann, Manuela Maspoli, Elisabetta Rapiti, Michel Grzebyk

Subjects: Get full text

Decrease in the number of new cancer diagnoses during the first year of the COVID-19 pandemic – cohort study of 3.5 million individuals in western Poland by Maciej Trojanowski, Piotr Radomyski, Piotr Radomyski, Witold Kycler, Irmina Maria Michalek

Subjects: Get full text

Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data by Semaw Ferede Abera, Ahmed Bedir, André Glowka, Dirk Vordermark, Daniel Medenwald

Subjects: Get full text

Age-Standardized Breast Cancer Detection Rates of Breast Cancer Screening Program by Age Group in Korea; Comparison with Age-Standardized Incidence Rates from the Korea Central Cancer Registry by Miye Kim, Hyeongsu Kim, Heejung Choi, MiSeon Son, Kun-Sei Lee, Tae-Hwa Han, Sollip Kim

“…To compare the epidemiological characteristics of a breast cancer screening program of patients between 40–69 years of age and ≥70 years of age, we calculated the age-standardized detection rate of the breast cancer screening program and compared it with the age-standardized incidence rate from the Korea Central Cancer Registry. The data of the breast cancer screening program from January 2009 to December 2016 and the data of the health insurance claims from January 2006 to August 2017 were used. …”
Get full text

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG by Dirk Schadendorf, Lucie Heinzerling, Jessica C Hassel, Lisa Zimmer, Ralf Gutzmer, Alexander Kreuter, Andrea Forschner, Elisabeth Livingstone, Bastian Schilling, Selma Ugurel, Peter Mohr, Thilo Gambichler, Patrick Terheyden, Sebastian Haferkamp, Friedegund Meier, Claudia Pfoehler, Dirk Debus, Rudolf Herbst, Carmen Loquai, Frank Meiss, Carsten Weishaupt, Jochen Utikal, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal, Maike Trommer, Jürgen Christian Becker, Ulrike Leiter, Cindy Franklin, Christoffer Gebhardt, Katharina Kahler, Leonie Bluhm, Imke Grimmelmann, Marlene Garzarolli, Dorothee Nashan, Michael Sachse, Julia Welzel, Gerhard Weyandt, Susanne Horn, Fabian Ziller, Harald Löffler, Stephan Grabbe, Gaston Schley, Georg Lodde, Jan-Malte Placke, Anca Sindrilaru

“…This study investigated differences in incidence and time to diagnosis of brain metastasis and survival outcomes dependent on the type of first-line therapy.Methods Patients with metastatic, non-resectable melanoma (AJCCv8 stage IIIC–V) without brain metastasis at start of first-line therapy (1L-therapy) were identified from the prospective multicenter real-world skin cancer registry ADOREG. Study endpoints were incidence of brain metastasis, brain metastasis-free survival (BMFS), progression-free survival (PFS), and overall survival (OS).Results Of 1704 patients, 916 were BRAF wild-type (BRAFwt) and 788 were BRAF V600 mutant (BRAFmut). …”
Get full text